Greater Glasgow and Clyde Medicines

All healthcare professionals involved in patient care have a responsibility to report suspected ADRs

Opioid choice
Patient factors
Indication
Observe
Independent check
Dose equivalence
Storage

MHRA Drug Safety Update for April 2022

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines assessed by SMC and considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary